Squint Metrics maintains its market-leading technology and development capabilities to deliver advanced promotional opportunities for pharmaceutical, biotech, pharmacy, and payer clients. In addition, Squint builds proprietary services to collect longitudinal data across large populations using clinically-validated, patient-reported outcome (PRO) measures. By delivering this actionable, real-world evidence, Squint aims to help form a more complete view of chronic disease intervention.
